Z3
General Information
DRACP ID DRACP00329
Peptide Name Z3
Sequence KAAKKAWKAWKKAAKAAWKKAA
Sequence Length 22
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
Meth A | Mouse fibrosarcoma | Sarcoma | EC50>211 µM | MTT assay | Not available | 1 |
MT-1 | Human mammary carcinoma | Carcinoma | EC50=128 µM | MTT assay | Not available | 1 |
HT-29 | Colon adenocarcinoma | Carcinoma | EC50>211 µM | MTT assay | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C117H190N34O23
Absent amino acids CDEFGHILMNPQRSTVY
Common amino acids A
Mass 281580
Pl 11.7
Basic residues 9
Acidic residues 0
Hydrophobic residues 13
Net charge 9
Boman Index -2486
Hydrophobicity -90
Aliphatic Index 45.45
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 16500
Absorbance 280nm 785.71
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22057278
Title Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available